WASHINGTON (PRWEB)
April 17, 2020

Configo Health Inc., a healthcare data and analytics company specializing in pediatrics, today announced the launch of its COVID-19 Recovery Accelerator, an online tool allowing children’s hospitals to scenario plan and optimize the managed ramp up of elective procedure volume. The tool will be offered free of charge to all hospitals and is accessible at http://covid.configohealth.com.

“Despite the lower COVID-19 symptom severity in pediatric patients, children’s hospitals have nevertheless experienced radical transformations to their operations to reduce disease transmission. Elective surgeries have dropped to unprecedentedly low volumes with dramatic impact on already tight operating margins,” said Craig Manson, CEO of Configo Health. “At Configo, we wanted to do our part to help the industry respond to this crisis. Our COVID-19 Recovery Accelerator will help administrators ensure continued adherence to disease prevention measures, while optimizing the use of available resources to start processing the elective surgery backlog.”

The tool, which has been developed in consultation with the team from Configo investor Children’s National Hospital, has been designed to be a collaborative project. As hospital users provide specific feedback regarding their needs, the Configo team will continue to iterate and improve the product.

“To respond to the ongoing impact of COVID-19 within pediatrics, we pivoted our product and technology teams to build the Accelerator; moving from ideation to launch within seven days,” said Evan Jones, COO of Configo Health. “Configo will continue to improve the tool as we engage with the children’s hospital community.”

Dr. Rahul Shah, vice president, chief quality and safety officer at Children’s National Hospital added, “Although today we are focused on reducing disease spread, we must start planning for how we will bring normal operations back online in a prudent and efficient manner. The Configo COVID-19 Recovery Accelerator is an invaluable tool in aiding our preparations for a return to such operations.”

About Configo Health, Inc.

Configo Health is a healthcare data and analytics company, focused specifically on pediatrics, that helps children’s hospitals and their patients and families make better decisions through the use of actionable insight. Experts in extracting administrative data from pediatric hospitals, Configo Health provides HIPPA compliant processes, secure data storage facilities, data cleansing and sophisticated analytical processing. Configo Health has offices in both New York and Washington D.C.

Share article on social media or email:

LANOIR, N.C. (PRWEB)
April 17, 2020

AZ Labs is developing this innovative, patent pending, formulation as a homeopathic solution that helps alleviate symptoms of viral respiratory ailments. The product, Azvirex™, is intended to be a preventative or therapeutic aid that inhibits viral replication. Azvirex™, is in final development stages and agreements are in place with contract manufacturers to manufacture, package and market this unique homeopathic remedy.

The homeopathic product, Azvirex™ utilizes simple vaporization technology to deliver atomized zinc directly into the targeted organ, the lungs. This directeded delivery of zinc to the lower respiratory tract is intended to prevent and/or inhibit viral replication pathways of RNA viruses and other viral types (2,3,4) as well as some bacteria.

The Azvirex ™ formulation is based on multiple in-vitro and in-vivo studies that have demonstrated the efficacy of zinc ions in preventing and or inhibiting viral replication. Peer reviewed studies have shown zinc is involved in numerous aspects of cellular metabolism and is required for the catalytic activity of approximately 100 enzymes (5,6) and plays a key role in immune function (7,8).

Treatment with Azvirex ™ should provide similar or superior effectiveness for preventing or limiting the duration of the common cold (9) as compared to zinc lozenges and nasal sprays as it directly delivers zinc ions to both the upper and lower respiratory tract. These are the critical areas commonly affected by viral infections

For more information regarding AZ Labs Azvirex ™ formula, please visit http://www.azlabsnc.com. If you have any questions regarding information in the press release, please contact Max Azevedo at (828) 292-1905

1. Efficacy of Zinc Against Common Cold Viruses: An Overview Darrell Hulisz

2.Te Velthuis A., Van Den Worm S, Sims A, Barie R, Snijder E, Van Hermert M. Zn2+ inhibits coronavirus and arterivrus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010 Nov: 6(11) [ 1 0.13 71 ljouma l.pp at.100 1176 ]

3.Suara RO, Crowe JE Jr. Effects of zinc salts ofrespiratory syncytical virus replication. Antimicrob Agents Chemother., 2004 Mar, 48(3): 783-90.

4.Ishida, T. Antiviral activities of Zn2+ ions for viral prevention, replication, capsid protein and intracellular proliferation of viruses. WSN 97, 2018: 28-50.

5.Sandstead HH. Understanding zinc: recent observations and interpretations. J Lab Clin Med 1994;124:322-7. [PubMed abstract]

6.Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2001.

7.Solomons NW. Mild human zinc deficiency produces an imbalance between cell-mediated and humoral immunity. Nutr Rev 1998;56:27-8. [PubMed abstract]

8.Prasad AS. Zinc: an overview. Nutrition 1995;11:93-9. [PubMed abstract]

9.Prasad AS, Beck FW, Bao B, Snell D, Fitzgerald JT. Duration and severity of symptoms and levels of plasma interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate. J Infect Dis 2008 ;197:795-802. [PubMed abstract]

Share article on social media or email:

SANTA CLARITA, Calif. (PRWEB)
April 17, 2020

CR Environmental LLC is deploying medical level COVID decontamination service to sanitize businesses in Valencia, California. This is the first time this hospital grade sanitizing equipment is being used on local businesses.

CR Environmental is a IAC2 certified remediation company that offers COVID sanitation cleaning services for businesses to reduce their risk when reopening to the public.

The COVID decontamination process employs an EPA approved fog solution that leaves no toxic residue with no rinsing required. The equipment delivers a predetermined amount of mist based on the room size. This EPA registered solution has a 99.9999% efficacy rating against COVID and other difficult to kill bacteria. The efficient system is lab proven to decontaminate everything the mist touches. This advanced equipment is superior to traditional hand cleaning methods that often fail to reach the entire room.

CR Environmental LLC also specializes in non-toxic and non-VOC mold removal techniques that protect current and future occupants of the buildings they treat.

“In this critical time of reopening businesses, it is important that we protect the community we serve. Deep decontamination of public places and businesses is going to be paramount during this ‘re-opening’ process,” said Carl Reese the CEO of CR Environmental LLC.

Reese has been a repeat guest on Fox Business News with Liz Claman and has set multiple Guinness World Records to bring awareness to veterans and first responder charity called the Motorcycle Relief Project a 501(3)(c)

Tom Delgado, the company Field Operations Officer says, “The service is new to the Santa Clarita Valley, but the decontamination process has existed for over nine years. The equipment we use to decontaminate is also used in hospitals and medical facilities worldwide.”

About CR Environmental

CR Environmental LLC serves Los Angeles and Kern Counties, specializing in mold testing, mold remediation, and COVID decontamination of businesses and residences.

CR Environmental technicians must complete a forty-eight hour OSHA Hazwopers and Supervisor course.

For more about CR Environmental LLC go to https://www.covidsterilization.com

About Carl Reese

Carl Reese is the CEO of CR Environmental LLC. Reese is a certified OSHA Hazwoper Supervisor, IAC2 Certified Indoor Air Quality Specialist, NACHI Certified Property Inspector, Licensed General Contractor, Certified Thermographer, PPE Certified, IAC2 Remediation Certified, EPA Lead-Safe Renovator Certified.

Reese has served the Santa Clarita Valley since 1994, working closely with the medical community to provide environmental testing of residences and businesses alike.

Reese is a multiple Guinness World Record holding professional endurance driver.

For more about Carl Reese got to https://en.wikipedia.org/wiki/Carl_Reese_(driver)

For more about Motorcycle Relief Project go to http://www.motorelief.org

About Wes Colvin

Wes Colvin is the COO of CR Environmental. Colvin has served in senior executive level positions for more than 25 years guiding and shaping healthcare business strategy. Colvin most recently has serviced as the Assistant Chief Information Officer for the County of Riverside. Colvin also has been part time faculty for the University of La Verne and College of the Canyons. Colvin has an Executive MBA from Claremont Graduate University. Certificates and short business programs from CalTech, Harvard Business School, MIT, UCLA, Carnegie Mellon University and Cal Poly Pomona. Most recently, he has been enrolled in Health Care Management and Leadership at UCLA.

About Tom Delgado

Tom Delgado, Field Operations Officer of CR Environmental, has a Bachelor’s degree in business from CSUN and brings over 15 years of domestic and international medical sales experience in senior management roles. Delgado is a certified OSHA Hazwoper Supervisor, Santa Clarita resident, and local real estate agent.

Share article on social media or email:

CLEVELAND and PALO ALTO, Calif. (PRWEB)
April 16, 2020

Centers for Dialysis Care, the largest dialysis provider in Northeast Ohio, and Dossier, Inc., a leading provider of cloud-based competency solutions for health systems globally, today announced that Centers for Dialysis Care has selected Dossier as its competency assurance solution.

For over 45 years, the Centers for Dialysis Care has been a leading innovator and non-profit independent provider of outstanding patient-focused dialysis treatments, kidney education, and home dialysis support and training. They are committed to setting the highest standard of quality, assuring that every detail of the patient’s care is administered with skill and compassion.

One of the most inefficient and time-consuming aspects of operating a dialysis center is managing and organizing the often paper-based competency requirements as set by the organization and regulatory agencies.

“We have been struggling to gain visibility into the real-time status of all clinical and non-clinical employees’ competencies across our 20 facilities,” said Gayle Nemecek, COO of Centers for Dialysis Care. “It is critical to our operation to ensure we maintain the highest standards of care as our organization grows, and have immediate access to documentation which is necessary for maintenance of regulatory requirements. Dossier’s cloud-based solution helps us achieve our vision to be the provider of choice as the most trusted community partner for high quality, patient-centered kidney healthcare.”

“Dossier is thrilled to partner with a local, like-minded company committed to quality patient care through ensuring capability and competence at the point of care,” Roger Lee, President of Dossier. “Centers for Dialysis Care’s use of this technology proves it is possible for an organization to ensure delivery of high quality services, no matter where a patient seeks treatment. We are proud to work with Centers for Dialysis Care to further develop functionality in Dossier as this important segment demonstrates the need for management of all quality care documentation in an expanding footprint caring for an important patient population.”

About Dossier, Inc.

Dossier is a leading provider of cloud-based competency assurance and management solutions for health systems globally. We drive meaningful, measurable results for more than 500,000 healthcare workers. For more information, please visit https://www.DossierHealthcare.com

About Centers for Dialysis Care

The Centers for Dialysis Care is a leader in providing patient-centered quality care to all individuals with kidney disease. Since 1974, Centers for Dialysis Care has been a non-profit independent provider of dialysis and related health services and a leading innovator of renal care in Northeast Ohio. With 20 locations across Cuyahoga, Lake, Ashtabula, Mahoning and Trumbull county, Centers for Dialysis Care is proud to be a growing organization that rapidly responds to changes, attracts and retains quality staff, and collaborates with physicians, other healthcare providers, and payors. For more information, visit http://www.cdcare.org.

For more information, contact:

Elizabeth Green

Centers for Dialysis Care

(216) 229-1100

egreen@cdcare.org

Roger Lee

Dossier, Inc.

(408) 679-7532

Roger.Lee@dossier.com

Share article on social media or email:

NEW YORK (PRWEB)
April 16, 2020

A new study from the Icahn School of Medicine at Mount Sinai suggests that blood clots, especially in the lungs, may play a role in severe cases of COVID-19. The finding suggests that treatment for respiratory failure caused by COVID-19 might follow the model for stroke—anticoagulation drugs for milder cases and thrombolysis, or clot removal, with continued anticoagulation for more severe disease.

The researchers found that critically ill COVID-19 patients have relatively well-preserved lung mechanics despite severe gas exchange abnormalities, a feature not consistent with classical acute respiratory distress syndrome (ARDS), but one that is more consistent with pulmonary vascular disease.

SARS-CoV-2, the virus that causes COVID-19, is closely related to SARS-CoV-1, the virus that caused the SARS outbreak in 2003. Previous autopsy studies from SARS cases demonstrated pulmonary thrombi, pulmonary infarcts, and microthrombi in other organs. Pulmonary thrombi are blood clots in the lungs that can cause pulmonary infarcts, the death of lung tissue due to lack of blood supply. Now, studies show that SARS-CoV-2 appears to be causing similar pathophysiological derangements. Although microthrombi, clots in small blood vessels, are present in sepsis and classic forms of ARDS, they are not the principal drivers of respiratory failure and organ dysfunction in those cases. In COVID-19 pneumonia, the thrombi may play a direct and significant role in gas exchange abnormalities and in multisystem organ dysfunction, the Mount Sinai researchers said.

The researchers observed five cases of COVID-19 patients at Mount Sinai Health System hospitals with refractory respiratory failure requiring mechanical ventilation and shock. Significant pulmonary microthrombi and/or macrothromboses were suspected to be serving as drivers of this pre-terminal state. The patients were administered tPA, a thrombolyic agent used to dissolve blood clots. All cases showed rapid improvement in alveolar ventilation, oxygenation, and/or shock.

These five cases had respiratory failure early in their COVID-19 course along with evidence of the “pulmonary vascular” phenotype, such as elevated protein fragments that are produced when a blood clot gets dissolved in the body and increased dead space, or air that is inhaled but does not take part in the gas exchange. Based on these findings, the researchers said, it may be prudent to consider full systemic anticoagulation—medication that is used to prevent the formation of blood clots—to mitigate disease progression in early stages and thrombolysis, in which clots are dissolved using thrombolytic agents, such as tPA, for more serious cases.

“It seems that for at least a significant subset of these patients, the underlying driver of respiratory failure and organ dysfunction is actually thrombosis and endothelial dysfunction,” said Hooman Poor, MD, Assistant Professor of Medicine (Pulmonary, Critical Care and Sleep Medicine) at the Icahn School of Medicine at Mount Sinai. “Future clinical trials will need to evaluate the role of anticoagulation for milder disease and thrombolysis for more severe disease.”

The high prevalence of obesity, hypertension, and diabetes in patients with severe COVID-19 pneumonia may point to an underlying susceptibility to endothelial injury and dysregulation, in which the inner lining of the small arteries fails to perform all of its important functions. The researchers advise that these therapeutic approaches should be considered in the management of COVID-19 patients and must be further examined in clinical research studies.

The Icahn School of Medicine at Mount Sinai, a top-ranked academic medical center in New York City, and National Jewish Health, the nation’s leading respiratory hospital based in Denver, Colorado, have partnered to create the Mount Sinai – National Jewish Health Respiratory Institute. To learn more about the Mount Sinai – National Jewish Health Respiratory Institute, visit our website, Facebook, or Twitter.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

The Dish on Health IT is focused on helping healthcare leaders in provider, payer and vendor organizations stay ahead of heath IT opportunities and policies that are changing the face of healthcare

HOLLYWOOD, Fla. (PRWEB)
April 16, 2020

Today, Point-of-Care Partners announced the launch of “The Dish on Health IT, a podcast focused on the latest health IT innovations, policies and industry shifts impacting U.S. healthcare delivery. During each podcast, a rotating panel of charismatic senior health IT experts will discuss game-changing health IT topics and trends to help subscribers stay ahead of new and emerging opportunities that lie within health IT.    

Curated for and by health IT and business leaders and sponsored by Point-of-Care Partners, the Dish on Health IT is available now on Apple Podcasts and Google Podcasts and other podcast listening apps. New episodes will be added every two weeks.    

The first podcast, Health IT in a COVID-19 World, is available now. During the 37-minute podcast, the expert panel discussed the role of health IT in addressing the perplexing issues surrounding the pandemic and how health IT is rapidly evolving to support positive change.

“The Dish on Health IT is focused on helping healthcare leaders in provider, payer and vendor organizations stay ahead of heath IT opportunities and policies that are changing the face of healthcare and do it in an entertaining format,” says Tony Schueth, CEO and Managing Partners of Point-of-Care Partners. “We will look at a given topic or issue through a multi-stakeholder lens to give listeners a holistic view of the health IT ecosystem and gain actionable insights for their organizations.”

Health IT leaders and the health IT curious may subscribe, view published podcasts and request topics for future podcasts on pocp.com.    

About Point-of-Care Partners

Point-of-Care Partners is a health IT management consulting firm with in-depth expertise in ePrescribing, eMedication management, health information exchange, population health management and multi-stakeholder initiatives. To learn more about how Point-of-Care Partners can help your company understand the changing health care landscape and implement effective strategies, contact info@pocp.com.

Related Links

The Dish on Health IT Podcast Channel

Apple Podcasts subscription

Google Podcasts subscription

Contacts

Point-of-Care Partners

Jeanette Nelson, 877-312-7627, ext. 4

Share article on social media or email:

CLEARWATER, Fla. (PRWEB)
April 16, 2020

easyMedicare.com (https://www.easyMedicare.com), an affiliate of e-TeleQuote Insurance, Inc., is proud to announce that Joe Theismann, former Super Bowl winning quarterback and NFL MVP, has joined the brand in its mission to make navigating Medicare easier. Theismann will play a vital role in easyMedicare.com’s efforts, including being featured in an integrated multimedia campaign.

Theismann played 12 seasons in the NFL, all with the Washington Redskins. His many athletic achievements include leading his team to victory in Super Bowl XVII and being named the league’s Most Valuable Player in 1983. Following his retirement from football, Theismann spent nearly 20 years in the broadcast booth for ESPN’s Sunday Night Football and Monday Night Football broadcasts. He is also a renowned public speaker, appearing at leadership events across the country. In addition, his motivational book, “How to be a Champion Every Day: 6 Timeless Keys to Success,” is scheduled for publication in June 2020.

Theismann attended the University of Notre Dame, an institution with a storied football tradition. While there he compiled a record of 20-3-2 as a starter. In 1970, Theismann earned honors as an All American. Even more impressively, he was named an Academic All American in that same year. In 2003, he was elected to the College Football Hall of Fame.

“Mr. Theismann’s long career and stellar reputation are a credit to his character, and we’re delighted to team up with him to spread the word about easyMedicare.com,” says Anthony P. Solazzo, CEO and Founder of e-TeleQuote. “With his partnership, we look forward to educating people and helping even more Americans find a Medicare plan that suits them.”

easyMedicare.com offers educational information and no-cost consultations from licensed agents via phone for residents of all 50 states. The agents assist people with the evaluation of Medicare plans in their area. The company also provides a self-service option with its online enrollment portal through which beneficiaries can find, compare, and enroll in Medicare plans fully online via their desktop computer or mobile device.

About e-TeleQuote and easyMedicare.com

e-TeleQuote Insurance, Inc., the owner and operator of easyMedicare.com, is an independent digital insurance marketplace providing individuals the ability to purchase Medicare insurance from the comfort of their homes. The company diligently researches available plan options from multiple insurance carriers, helping people choose a plan that best suits their needs. e-TeleQuote provides personal consultation through experienced licensed Medicare advisors who suggest plan coverage options based on an individual’s particular needs. The company has proudly served tens of thousands of people across the United States.

Share article on social media or email:

OMAHA, Neb. and EAST WINDSOR, N.J. (PRWEB)
April 16, 2020

Blue Cross and Blue Shield of Nebraska (BCBSNE) has selected SpectraMedix as its data analytics vendor to support collaboration with health care providers across the state.

BCBSNE’s Total Care program is a value-based model that reimburses providers based on the quality of care they coordinate instead of the number of services they perform. BCBSNE collaborates with Accountable Care Organizations (ACOs) and Patient-Centered Medical Home (PCMH) providers to deliver Total Care, and they rely on actionable data analytics to continually monitor quality and improve patient outcomes while lowering costs.

SpectraMedix works with health care organizations and offers cloud-based analytics applications to support value-based programs (VBP) like BCBSNE’s Total Care. BCBSNE will use SpectraMedix’s VBP Contract Modeler and VBP Performance Portal applications to effectively assess its member population, model contract parameters and generate reports. This will enable BCBSNE to provide ACOs with clinical, utilization and financial insights to manage care and costs.

SpectraMedix will also provide BCBSNE with comprehensive data mapping, validation and warehousing.

Blue Cross and Blue Shield of Nebraska Inc. has been leading the way in supporting patient-focused care since 1939. It is the state’s largest health insurance company, and the only one headquartered in Nebraska. BCBSNE is an independent licensee of the Blue Cross and Blue Shield Association. Learn more at NebraskaBlue.com.

SpectraMedix helps payers and providers make the most of their journey to value-based payment. Our flagship product, the VBP Performance Suite, supports health plans and their provider networks with an integrated suite of applications that streamline the process of VBP contracting, performance improvement, and provider enablement. It is powered by The SpectraMedix Platform™, a scalable, HIPAA compliant, NCQA certified cloud-based framework that is the cornerstone of all SpectraMedix applications. The Platform’s data integration capabilities include real-time EHR interfaces, including FHIR, and APIs can be leveraged to import data directly from EHR systems on-demand and in real-time. Download our Company Overview to learn more.

Share article on social media or email: